2019 Cannabis Clinical Trials Presentation 
Cannabis Law Report
JANUARY 13, 2020
12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.
Cannabis Law Report
FEBRUARY 2, 2022
UK website Leafie writes… The findings of a study published in JAMA Psychiatry have revealed that road testing for cannabis impairment may be putting up to 1.4m medical cannabis users at risk of unfair prosecution, according to a report by Volteface. Further simulator tests were given at 30 minutes, 1.5, hours after smoking.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MAY 31, 2022
The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. On March 5, 2019, the U.S. For obvious reasons, religious exemptions from the CSA do not present compelling opportunities for entrepreneurs. Schedule I.
The Cannigma
FEBRUARY 2, 2021
This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition.
The Cannigma
MARCH 7, 2022
Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. The best online schools for medical cannabis training.
Project CBD
AUGUST 6, 2019
Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. THC was present in 89 percent of the samples, but in most cases no amount of THC was provided.
PrestoDoctor
SEPTEMBER 15, 2023
However, recent research suggests that cannabis may be a promising option for those seeking relief from OCD symptoms. We’ll explore the ways in which cannabis can help ease OCD symptoms and compulsions and how to use it effectively. We’ll also examine the potential benefits and drawbacks of using cannabis to manage OCD.
Expert insights. Personalized for you.
66 
Let's personalize your content